Transient abnormal acylcarnitine profile in newborn screening mimicking multiple acyl-Coenzyme A dehydrogenase deficiency associated with maternal sertraline use
Rebecca Barbetti, Kate Coleman, Louise Fraser, Kalliope Demetriou, Elaine Jayadiwangsa, Drago Bratkovic, Carol Wai-Kwan Siu · 2026
Read Transient abnormal acylcarnitine profile in newborn screening mimicking multiple acyl-Coenzyme A dehydrogenase deficiency associated with maternal sertraline use by Rebecca Barbetti, Kate Coleman, Louise Fraser, Kalliope Demetriou, Elaine Jayadiwangsa, Drago Bratkovic, Carol Wai-Kwan Siu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13197719.txt.
Description
Newborn screening can flag a deadly metabolic disease called MADD, but a mother's medicine may paint the same picture in a healthy baby. The authors describe a well newborn, delivered by planned cesarean at term, whose day-two screen shows raised levels of several acylcarnitines, the classic MADD pattern. The mother took the antidepressant sertraline through pregnancy and up to delivery. The baby stays well, with normal blood sugar and lactate in the first hours.
A repeat profile on day five is improving, and by day twelve the values are normal. Urine tests mildly support the MADD-like pattern, yet a broad gene panel, including the three genes behind true MADD, finds nothing concerning. Adult cases with the same drug link were reported before. They conclude maternal sertraline belongs on the list of explanations reviewers should weigh before treating a screen result as real disease.
Catalog record
| CREATOR | Rebecca Barbetti, Kate Coleman, Louise Fraser, Kalliope Demetriou, Elaine Jayadiwangsa, Drago Bratkovic, Carol Wai-Kwan Siu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |